Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery

New England Journal of Medicine

Volumn 336, Issue 2, 1997, Pages 92-99

  Hlatky, Mark A ^a   Rogers, William J ^b   Johnstone, Iain ^a   Boothroyd, Derek ^a   Brooks, Maria Mori ^c   Pitt, Bertram ^d   Reeder, Guy ^e   Ryan, Thomas ^f   Smith, Hugh ^e   Whitlow, Patrick ^g   Wiens, Robert ^h   Mark, Daniel B ⁱ   Rosen, Allan D ^c   Detre, Katherine ^c   Frye, Robert L ^e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e MAYO CLINIC   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FUNCTIONAL ASSESSMENT; HEALTH CARE COST; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY DISEASE; COST-BENEFIT ANALYSIS; DIABETES COMPLICATIONS; EMPLOYMENT; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE;

EID: 8044221503     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199701093360203     Document Type: Article

References (45)

1. Grüntzig AR, Senning Å, Siegenthaler WE. Nonoperative dilatation of coronary artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979;301:61-8.
2. RITA Trial Participants. Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet 1993;341:573-80.
3. Rodriguez, A, Boulton F, Perez-Balino N, Paviotti C, Liprandi MI, Palacios IF. Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI): in-hospital results and 1-year follow up. J Am Coll Cardiol 1993;22:1060-7.
4. Goy JJ, Eeckhout E, Burnand B, et al. Coronary angioplasty versus left internal mammary artery grafting for isolated proximal left anterior descending artery stenosis. Lancet 1994;343:1449-53.
5. Hamm CW, Reimers J, Ischinger T, Rupprecht H-J, Berger I, Bleifeld W. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med 1994;331:1037-43.
6. King SB III, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 1994;331:1044-50.
7. CABRI Trial Participants. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). Lancet 1995;346: 1179-84.
8. Protocol for the Bypass Angioplasty Revascularization Investigation. Circulation 1991;84:Suppl V:V-1-V-27.
9. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335:217-25.
10. Pocock SJ, Henderson RA, Rickards AF, et al. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 1995;346:1184-9.
11. Sim I, Gupta M, McDonald K., Bourassa MG, Hlatky MA. A metaanalysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multivessel coronary artery disease. Am J Cardiol 1995;76:1025-9.
12. Bourassa MG, Roubin GS, Detre KM, et al. Bypass Angioplasty Revascularization Investigation: patient screening, selection, and recruitment. Am J Cardiol 1995;75:3C-8C.
13. Rogers WJ, Alderman EL, Chairman BR, et al. Bypass Angioplasty Revascularization Investigation (BARI): baseline clinical and angiographic data. Am J Cardiol 1995;75:9C-17C.
14. Williams DO, Baim DS, Bates E, et al. Coronary anatomic and procedural characteristics of patients randomized to coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Cardiol 1995;75:27C-33C.
15. Schaff HV, Rosen AD, Shemin RJ, et al. Clinical and operative characteristics of patients randomized to coronary artery bypass surgery in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Cardiol 1995;75:18C-26C.
16. Ferguson JJ. American Heart Association 68th Scientific Sessions, Anaheim, California, November 13 to 15, 1995. Circulation 1996;93:843-6.
17. Hlatky MA, Charles ED, Nobrega F, et al. Initial functional and economic status of patients with multivessel coronary artery disease randomized in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Cardiol 1995;75:34C-41C.
18. Hlatky MA, Boineau RE, Higginbotham MB, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989;64:651-4.
19. Nelson CL, Herndon JE, Mark DB, Pryor DB, Califf RM, Hlatky MA. Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status Index. Am J Cardiol 1991;68:973-5.
20. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey: reliability and validity in a patient population. Med Care 1988;26: 724-35.
21. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions: results from the Medical Out comes Study. JAMA 1989;262:907-13. [Erratum, JAMA 1989;262:2542.]
22. Stewart AL, Ware JE Jr, eds. Measuring functioning and well-being: the Medical Outcomes Study approach. Durham, N.C.: Duke University Press, 1992.
23. Ware JE Jr. SF-36 Health survey: manual and interpretation guide. Boston: Health Institute, New England Medical Center, 1993.
24. Finkler SA. The distinction between costs and charges. Ann Intern Med 1982;96:102-9.
25. Statistical abstract of the United States, 1994. 114th ed. The national data book. Lanham, Md.: Bernan Press, 1995.
26. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977;296:716-21.
27. Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford, England: Oxford University Press, 1987.
28. Etzioni R, Urban N, Baker M. Estimating the costs attributable to a disease with application to ovarian cancer. J Clin Epidemiol 1996;49:95-103.
29. Efron B, Tibshirani R. Statistical data analysis in the computer age. Science 1991;253:390-5.
30. Idem. An introduction to the bootstrap. New York: Chapman & Hall, 1993.
31. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
32. Peduzzi P, Hultgren H, Thomsen J, Detre K. Ten-year effect of medical and surgical therapy on quality of life: Veterans Administration Cooperative Study of Coronary Artery Surgery. Am J Cardiol 1987;59:1017-23.
33. European Coronary Surgery Study Group. Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982;2:1173-80.
34. Rogers WJ, Coggin CJ, Gersh BJ, et al. Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery: the Coronary Artery Surgery Study (CASS). Circulation 1990;82:1647-58.
35. Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992;326:10-6.
36. Mark DB, Lam LC, Lee KL, et al. Effects of coronary angioplasry, coronary bypass surgery, and medical therapy on employment in patients with coronary artery disease: a prospective comparison study. Ann Intern Med 1994;120:111-7.
37. Mark DB, Lam LC, Lee KL, et al. Identification of patients with coronary disease at high risk for loss of employment: a prospective validation study. Circulation 1992;86:1485-94.
38. Jang GC, Block PC, Cowley MJ, et al. Relative cost of coronary angioplasty and bypass surgery in a one-vessel disease model. Am J Cardiol 1984;53:52C-55C.
39. Kelly ME, Taylor GJ, Moses HW, et al. Comparative cost of myocardial revascularization: percutaneous transluminal angioplasty and coronary artery bypass surgery. J Am Coll Cardiol 1985;5:16-20.
40. Hlatky MA, Lipscomb J, Nelson C, et al. Resource use and cost of initial coronary revascularization: coronary angioplasty versus coronary bypass surgery. Circulation 1990;82:Suppl IV:IV-208-IV-213.
41. Reeder GS, Krishan I, Nobrega FT, et al. Is percutaneous coronary angioplasty less expensive than bypass surgery? N Engl J Med 1984;311: 1157-62.
42. Sculpher MJ, Seed P, Henderson RA, et al. Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet 1994;344: 927-30.
43. Rodriguez A, Mele E, Peyregne E, et al. Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI). J Am Coll Cardiol 1996;27:1178-84.
44. Weintraub WS, Mauldin PD, Becker E, Kosinski AS, King SB III. A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease: results from the Emory Angioplasty Versus Surgery Trial (EAST). Circulation 1995;92: 2831-40.
45. Goldman L, Garber AM, Grover SA, Hlatky MA. Matching the intensity of risk factor management with the hazard for coronary disease events: Task Force 6: cost effectiveness of assessment and management of risk factors. J Am Coll Cardiol 1996;27:1020-30.